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Summary
Objectives: We studied the electroencephalographic (EEG) and behavioral changes of the chemical model of generalized absence epilepsy 
induced by acute and chronic administration of gamma-butrolactone (GBL), a prodrug of gamma-hydroxybutyric acid.
Methods: Adult male Wistar rats under anesthesia were implanted with bilateral cortical recording electrodes. The rats were administered 
30 intraperitoneal injections of GBL twice daily from Monday to Friday and EEG was recorded 20 min before and 40 min after GBL injections. 
In order to monitor spontaneous spike-and-wave discharges (SWDs), the baseline EEGs on the subsequent Monday mornings after the first, 
second and third weekends were recorded for 90 min.
Results: The intraperitoneal administration of GBL caused a rapid onset of bilaterally synchronous SWDs in the cortical EEG accompanied by 
behavioral immobility, vacant-staring and vibrissal twitching. By repeated GBL injections, animals displayed spontaneous bilateral synchro-
nous SWDs in the baseline EEG on the Monday morning session after the   GBL-free weekend period (60 h after the Friday afternoon injection).
Conclusion: The present study reports the acute and chronic effects of the systemic administration of GBL. The chronic systemic application 
of GBL may represent a model of epileptogenesis for absence epilepsy.
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Özet
Amaç: Çalışmamızda, gama-hidroksibutiratın (GHB) ön ilacı olan gama-butirolakton (GBL) ile indüklenmiş kimyasal jeneralize absans epilepsi 
modelinde GBL’nin akut ve kronik uygulanmasıyla oluşan EEG ve davranış değişiklikleri incelendi.
Gereç ve Yöntem: Çalışmada kullanılan yetişkin Wistar sıçanlara, anestezi altında stereotaksik cerrahi yöntemi uygulandı; hayvanlara iki ta-
raflı kortikal kayıt elektrotları implante edildi. Bir haftalık iyileşme sürecini takiben sabah ve akşam olmak üzere günde iki kez i.p. GBL enjek-
siyonu uygulandı. Enjeksiyon uygulamasından önceki 20 dakika, sonrasında 40 dakika olmak üzere EEG kaydı alındı, enjeksiyon yapılmadan 
geçen haftasonlarını takiben Pazartesi sabahları enjeksiyon öncesi 40 dakika bazal EEG kaydı alındı.
Bulgular: Bu çalışmada sistemik GBL uygulamasının akut ve kronik etkileri tekrar ortaya kondu. Çalışmamızda yer alan hayvanlarda, tekrarla-
yan enjeksiyonlarla birlikte, enjeksiyon yapılmadan geçen haftasonlarını takiben Pazartesi sabahları enjeksiyon öncesi alınan bazal kayıtlarda 
spontan iki taraflı DDD’leri görüldü.
Sonuç: Kronik sistemik GBL uygulanması absans epilepsi için bir epileptogenez modeli ortaya koyabilir. GHB modeli antiepileptik ilaç araştır-
malarında, absans epilepsi modeli olarak kullanılabilir.
Anahtar sözcükler: Absans epilepsi; gama-butirolakton; wistar sıçanlar; EEG.
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EXPERIMENTAL STUDY / DENEYSEL ÇALIŞMAIntroduction
A pharmacological modeling approach to absence epilepsy 
requires a reproducible and predictable method that has 
the EEG and behavioral characteristics of generalized typi-
cal absence seizures in humans. The gamma-hydroxybutyr-
ate (GHB) and gamma-butryrolactone (GBL) models meets 
these criteria.[1,2] The acute administration of GBL, which is 
a prodrug of GHB, has been shown to produce exactly the 
same EEG and behavioral effects of absence seizures as GHB 
[3] and GBL administration mimics typical absence epilepsy 
in humans.[4] GBL is preferred due to the consistency, pre-
dictable dose response and rapidity of the onset of its ac-
tion in rodents.[5-7] The systemic administration of a single 
dose of GBL produces absence seizures through the poten-
tiation of the GHB-related neuromodulation and/or interac-
tion with GABAergic inhibitory and excitatory neurotrans-
mission in the cortico-thalamo-cortical circuit. 
The objective of this study was to determine the EEG and 
behavioral changes induced by acute and chronic adminis-
tration of GBL in male adult Wistar rats.
Materials and Methods 
Animals
Adult (6-8 months old) Wistar male rats (n=20) weighing 
270-300 g were used for all experiments. Animals were 
housed in a temperature controlled room (20±3 ºC) with a 
12-h light–dark cycle in groups of four per cage and sepa-
rated individually after the surgery with free access to com-
mercial rat pellets and tap water. The experimental protocol 
was approved by the Animal Care and Use Committee of 
Marmara University (48.2011.mar). 
Surgery
Animals were anaesthetized with ketamine (100 mg/kg, 
intraperitoneally) and xylazine (10 mg/kg, intraperitone-
ally). Rats was placed in a stereotaxic instrument (Stoelting 
Model 51600, Stoelting Co., Illinois, USA) with the skull sur-
face flat and bregma 0.0[8] and then the scalp was longitudi-
nally incised for the implantation of stainless steel screws, 
for epidural recording and ground, placed bilaterally in 
the skull over frontal and parietal cortices for the record-
ing of electroencephalogram (EEG). All of the electrodes 
were fixed to the skull with dental acrylic and in turn linked 
by insulated wires to a connector for EEG recordings. The 
animals were allowed to recover from surgery for 1 week 
before any experimental protocols were started. 
Experimental protocol
On the first day of the experiment, all animals were placed 
in Plexiglas recording cages. After an adaptation period, a 
baseline EEG was recorded for 20 min from as indicated in 
the experimental design. Electrical activity of the cortex was 
amplified (BioAmp ML 136) and recorded with a PowerLab 
8S System running Chart v.5, (ADI Instruments, Oxfordshire, 
U.K.) before and after each GBL injection. GBL was pur-
chased from Sigma Aldrich (St Louis, U.S.A) and prepared in 
saline for the intraperitoneal injection, a dose of 100 mg/kg 
of GBL was chosen based on the previous literature.[6,7] GBL 
has been shown to be readily hydrolyzed in vivo to its active 
congener, GHB.[9]
The rats were administered 30 intraperitoneal injections of 
GBL twice daily from Monday to Friday. The EEG was record-
ed continuously 90 min after the first GBL injection to deter-
mine the duration of the acute GBL effect. Then for the rest 
of the week, EEG was recorded 20 min before and 40 min 
after GBL injections to evaluate GBL-induced discharges 
with chronic administration of GBL throughout the 3 weeks. 
In order to monitor spontaneous SWDs, the baseline EEGs 
on the subsequent Monday mornings after the first, second 
and third weekends were recorded for 90 min.
A GBL-induced discharge was identified visually as such 
if its duration was ≥1 s with a complex of spike-and-wave 
(5-6 Hz) and amplitude at least three times the background 
amplitude of the EEG. The GBL-induced discharges were 
referred as SWDs captured on the EEG and the cumulative 
and mean duration of SWDs.
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Figure 1. The cumulative duration of SWDs after the first GBL 
injections over a 40 min period (*p<0.05).
0-10 10-20
Time (min)
20-30 30-40
*
0
20
10
30
40
C
u
m
u
l
a
t
i
v
e
 
S
W
D
 
d
u
r
a
t
i
o
n
 
(
s
e
c
)
GBL inj.The Gamma-Butyrolactone Model of Absence Epilepsy
50
The effect of acute GBL administration
The intraperitoneal administration of GBL caused a rapid 
onset of bilaterally synchronous discharges in the cortical 
EEG accompanied by behavioral immobility, vacant-staring 
and vibrissal twitching. The SWD appeared 4.8±1.25 min 
after the first injection of GBL, reached maximum numbers 
and durations within 20 min (Figure 1). These complexes 
became regular, waxing and waning rhythmic SWDs with 
repeated chronic administration. The latency to onset of 
the first SWD complex was found to be delayed by repeated 
injections of GBL and reached 12.1±3.8 min after the 30th 
injection. The cumulative duration of SWDs by repeated 
chronic administration of GBL reached its maximum within 
20 min as observed in the acute injections (Figure 2).
Statistical analysis
Data expressed as mean ± SEM were statistically evaluated 
by analysis of variance of repeated measures (ANOVA). A 
one-way ANOVA followed by the post hoc Bonferroni test 
was used to analyze cumulative duration of SWDs after the 
first GBL injection as well as the cumulative and mean dura-
tion of spontaneous SWDs after the first, second and third 
weekends in the GBL group. The level of statistical signifi-
cance was considered to be p<0.05.
Results
The baseline EEG recordings of all Wistar rats showed no ab-
normal discharges.
Figure 4.  The cumulative duration of spontaneous SWDs 
throughout the 3-weeks experimental period, during 
the chronic GBL systemic administration (*p< 0.05).
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Figure 3. The mean duration of spontaneous SWDs throughout 
the 3-weeks experimental period, during the chronic 
GBL systemic administration.
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Figure 2. The effect of repeated chronic administration of GBL. The changes of cumulative SWD duration by 
repeated injections of GBL during the 40 min post injection periods.
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The effect of chronic GBL administration
By repeated intraperitoneal injections of GBL, animals dis-
played spontaneous bilateral synchronous SWDs in the 
baseline EEG on the Monday morning session after the 
GBL-free weekend period (60 h after the Friday afternoon 
injection). The cumulative and mean duration of spontane-
ous SWDs increased throughout the 3-weeks experimental 
period in the chronic administration (Figure 3 and 4). The 
statistical analysis revealed a significant increase in cumula-
tive duration of spontaneous SWDs after the third weekend.
Discussion
The present study demonstrates that in animals received 
chronic administration of GBL, the GBL-induced discharges 
consisting of spike-and-wave complexes became more 
typical or mature form of SWD over the repeated intraperi-
toneal injections of 100 mg/kg. 
Additionally, the EEG characteristics of GBL-induced dis-
charges with the acute administration of the dose of 100 
mg/kg are in line with the previous observations.[6,10,11] The 
initial electrographic change in the baseline EEG recorded 
from the right and left frontoparietal cortices was a brief 
burst of spikes and thereafter quickly progressed to typi-
cal SWDs of absence seizures as has been reported previ-
ously by Snead.[6] These GBL-induced bilateral synchronous 
discharges in the acute administration show irregularity in 
rhythmicity, duration and amplitude. These electrographic 
discharges after the first injections were similar to the im-
mature SWD paroxysms observed in postnatal 30 days old 
GAERS.[12] With repeated chronic administration of GBL, 
the SWD complexes appeared to mature with an increase 
in the power at the fundamental frequency and similar to 
that in adult GAERS or WAG/Rij rats.[13] It is accepted that 
the major disadvantage of the GHB and GBL models is that 
they represent an acute model of absence seizures rather 
than a chronic model of absence epilepsy such as the ge-
netic models.[2] However, the maturation of GBL-induced 
SWDs over the time and spontaneous SWDs after the 
weekends in the present study indicated a fully synchro-
nized paroxysmal activity, suggesting an augmentation in 
the cortico-thalamo-cortical network with repeated GBL 
administrations. The brief spontaneous bursts of bilaterally 
synchronous SWDs have been previously observed follow-
ing the acute administration of GBL late as 72 h.[14] Indeed, 
the involvement of the cortico-thalamo-cortical circuitry 
has been well accepted in the pathophysiology of absence 
epilepsy based on the studies in the genetic and chemical 
absence epilepsy models.[15-17] This synchronized paroxys-
mal activity with the chronic administration of GBL sug-
gests a change over time in the functional organization of 
absence seizure circuit that possibly occurs at the cellular 
and/or synaptic level in the thalamo-cortical circuitry. Tak-
en together the chronic systemic application of GBL may 
represent an epileptogenesis model for absence epilepsy 
itself, deserving a particular attention in further studies.
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